Appointment of New CEO
Filed with ASX · · 3 pages · English
Summary by 6ix AI
CSL Limited has announced the appointment of Deborah Waterhouse as CEO and Managing Director, effective from February next year. The decision follows a comprehensive global search conducted by the Board of Directors. The current Interim CEO, Gordon Naylor, will transition to a non-Executive Director role after Ms. Waterhouse takes over.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from CSL
- CSL dan Alentis umum perkongsian global untuk membangunkan dan mengkomersialkan lixudebart bagi penyakit buah pinggang dan hati yang jarang berlaku
- CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases
- CSL และ Alentis ประกาศความร่วมมือระดับโลก เพื่อพัฒนาและทำการตลาดยา lixudebart สำหรับโรคไตและตับที่พบได้ยาก
- CSL enters exclusive agreement with Alentis Therapeutics
- CSL Seqirus Expands U.S. Availability of Influenza Vaccine following Successful Completion of the 2026/27 Manufacturing Campaign
Later from CSL
All CSL news releasesFollow CSL into a list and get an email when it puts out news.
Follow CSL